Not Signed In - Fortune Examines Challenges For Over-The-Counter Approval Of OraQuick Oral HIV Test
Sat, 20 May 2006 03:00 PM EST
... Fortune magazine in its May 29 edition examines the challenges OraSure Technologies faces in obtaining FDA approval for over-the-counter sales of its oral OraQuick Advance Rapid HIV 1/2 Antibody Test, which some analysts predict might not happen for 18 months (Simons, Fortune, 5/29). The OraQuick test requires users to swab their gums and then place the swab in a holder. [click link for full article] ...
Related Topics
- HIV Antibody
- HIV/AIDS & STDs
- HIV Testing
- Over-the-Counter Medicines
- Home Tests
- Antibody Tests
- Tests
- Diagnostic Tests
- Acquired Immune Deficiency Syndrome
- Laboratory Tests
- Pregnancy Test
- Vaccine Testing & Approval
- Oral Cancer
- Perinatal HIV
- Oral Health
- Polio Vaccine & Origin of HIV/AIDS
- Iron Tests
- Healthcare Workers
- Teniposide
- Amoxicillin Oral Suspension
email this page
print this page
bookmark this page
feedback on this page
